| scholarly article | Q13442814 |
| P50 | author | Mark Shlomchik | Q29887913 |
| P2093 | author name string | Michael Kashgarian | |
| Daniel Kim | |||
| Sean R Christensen | |||
| Jonathan Shupe | |||
| Keith Elkon | |||
| Kevin M Nickerson | |||
| P2860 | cites work | AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC | Q24319706 |
| AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA | Q24319765 | ||
| An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome | Q24319799 | ||
| Trex1 prevents cell-intrinsic initiation of autoimmunity | Q24648757 | ||
| Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation | Q24676343 | ||
| Novel packages of viral and self-antigens are generated during apoptosis | Q27485110 | ||
| The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses | Q27860685 | ||
| HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA | Q28585347 | ||
| Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA | Q28587147 | ||
| Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus | Q29615029 | ||
| Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors | Q29615065 | ||
| Recognition of cytosolic DNA activates an IRF3-dependent innate immune response | Q29616156 | ||
| Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 | ||
| Oligoclonality of rheumatoid factors arising spontaneously in lpr/lpr mice | Q68256179 | ||
| Phenotypes of immunocompetent cells and Ia antigen expression in oral mucosa and skin of autoimmune mouse strains | Q69855378 | ||
| Dermatopathological studies on skin lesions of MRL mice | Q70379621 | ||
| Murine lupus in the absence of alpha beta T cells | Q71059502 | ||
| Propagation and regulation of systemic autoimmunity by gammadelta T cells | Q71860211 | ||
| The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies | Q72812865 | ||
| Genetic dissection of vasculitis in MRL/lpr lupus mice: a novel susceptibility locus involving the CD72c allele | Q74165048 | ||
| Pathogenesis of autoimmunity in alphabeta T cell-deficient lupus-prone mice | Q74211567 | ||
| Blebs and apoptotic bodies are B cell autoantigens | Q74334880 | ||
| Perforin protects against autoimmunity in lupus-prone mice | Q74463426 | ||
| Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE | Q79785802 | ||
| Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus | Q79834758 | ||
| Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms | Q79946741 | ||
| Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus | Q80219157 | ||
| Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice | Q80238431 | ||
| Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production | Q80358480 | ||
| Interaction of mutant lpr gene with background strain influences renal disease | Q93612765 | ||
| Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. | Q34566135 | ||
| Toll-like receptors in systemic autoimmune disease | Q34576448 | ||
| Host modifier genes affect mouse autoimmunity induced by the lpr gene | Q35764934 | ||
| TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. | Q36228411 | ||
| Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci | Q36232118 | ||
| Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes | Q36363024 | ||
| Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus | Q36403146 | ||
| RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. | Q36403678 | ||
| Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules | Q36535512 | ||
| Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors | Q36726933 | ||
| Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors | Q36727307 | ||
| TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity | Q36811126 | ||
| Innate and adaptive immune response to apoptotic cells | Q36948827 | ||
| Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity | Q36990647 | ||
| Nucleic acid recognition receptors in autoimmunity. | Q37028836 | ||
| Turning NF-kappaB and IRFs on and off in DC. | Q37183815 | ||
| IL-1, IL-18, and IL-33 families of cytokines | Q37211243 | ||
| Development of TLR inhibitors for the treatment of autoimmune diseases | Q37211279 | ||
| When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction | Q37217884 | ||
| Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus | Q37274484 | ||
| Toll-like receptors in autoimmunity | Q37348426 | ||
| Innate immunity to virus infection. | Q37361448 | ||
| Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice | Q37378097 | ||
| The innate immune response to DNA. | Q37508443 | ||
| The functional effects of physical interactions among Toll-like receptors 7, 8, and 9. | Q38308562 | ||
| Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing | Q39849800 | ||
| Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice | Q40231922 | ||
| Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice | Q40682091 | ||
| A rheumatoid factor transgenic mouse model of autoantibody regulation | Q41523682 | ||
| Frequency and epitope recognition of anti-ribosome P antibodies from humans with systemic lupus erythematosus and MRL/lpr mice are similar | Q41808133 | ||
| T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells | Q41831629 | ||
| The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation | Q42525772 | ||
| Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation | Q42972278 | ||
| Analysis of antibodies to RNA in patients with systemic lupus erythematosus and other autoimmune rheumatic diseases | Q44154557 | ||
| Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. | Q47368420 | ||
| Nucleosomes are exposed at the cell surface in apoptosis. | Q47579101 | ||
| Specificities and genetic characteristics of nucleosome-reactive antibodies from autoimmune mice | Q48067825 | ||
| V region gene analysis of anti-Sm hybridomas from MRL/Mp-lpr/lpr mice | Q48132884 | ||
| Plasma cells for a lifetime? | Q52013650 | ||
| B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. | Q52032016 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| autoantibody | Q785022 | ||
| murine model | Q122890741 | ||
| P304 | page(s) | 1840-1848 | |
| P577 | publication date | 2010-01-20 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus | |
| P478 | volume | 184 |
| Q93002620 | 17β-Estradiol and 17α-Ethinyl Estradiol Exhibit Immunologic and Epigenetic Regulatory Effects in NZB/WF1 Female Mice |
| Q42290162 | A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens |
| Q38318048 | A Toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-induced psoriasis |
| Q44175614 | A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice |
| Q39579822 | A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand binding |
| Q37394553 | A role for IRF8 in B cell anergy |
| Q35735423 | A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells |
| Q51067865 | Abnormal thymic maturation and lymphoproliferation in MRL-Fas lpr/lpr mice can be partially reversed by synthetic oligonucleotides: implications for systemic lupus erythematosus and autoimmune lymphoproliferative syndrome. |
| Q55402266 | Accelerated model of lupus autoimmunity and vasculopathy driven by toll-like receptor 7/9 imbalance. |
| Q38673417 | Age-associated B cells: key mediators of both protective and autoreactive humoral responses |
| Q45835397 | Aliskiren attenuates proteinuria in mice with lupus nephritis by a blood pressure-independent mechanism |
| Q90468943 | Alpha 1 Antitrypsin Gene Therapy Extends the Lifespan of Lupus-Prone Mice |
| Q33924642 | Altered B cell signalling in autoimmunity |
| Q36080732 | Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome |
| Q89266529 | Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus |
| Q45212505 | Are autoantibodies the targets of B-cell-directed therapy? |
| Q34420799 | Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9. |
| Q42321000 | Autoreactive helper T cells alleviate the need for intrinsic TLR signaling in autoreactive B cell activation |
| Q91964435 | B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments |
| Q64094881 | B Cell Dysfunction Associated With Aging and Autoimmune Diseases |
| Q36031630 | B Cell-Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus. |
| Q36532226 | B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice |
| Q35658606 | B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr) mice |
| Q34364711 | B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers. |
| Q90458171 | B cell-intrinsic TLR9 expression is protective in murine lupus |
| Q37509056 | B cell-specific loss of Lyn kinase leads to autoimmunity |
| Q52331790 | B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex. |
| Q39241954 | B-cell tolerance and autoimmunity. |
| Q36030578 | BANK1 Regulates IgG Production in a Lupus Model by Controlling TLR7-Dependent STAT1 Activation |
| Q33606019 | Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9 |
| Q92549917 | Below the surface: The inner lives of TLR4 and TLR9 |
| Q37983058 | Beyond transitional selection: New roles for BLyS in peripheral tolerance |
| Q47371480 | Bim suppresses the development of SLE by limiting myeloid inflammatory responses. |
| Q34965726 | Bruton's tyrosine kinase mediates the synergistic signalling between TLR9 and the B cell receptor by regulating calcium and calmodulin |
| Q42234851 | Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells |
| Q37415233 | CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP. |
| Q43213271 | Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses |
| Q47221189 | Co-Stimulation of BCR and Toll-Like Receptor 7 Increases Somatic Hypermutation, Memory B Cell Formation, and Secondary Antibody Response to Protein Antigen |
| Q36181690 | Commensal Microbe-specific Activation of B2 Cell Subsets Contributes to Atherosclerosis Development Independently of Lipid Metabolism |
| Q38170793 | Contributions of B cells to lupus pathogenesis |
| Q40608991 | Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells. |
| Q35617573 | Cytokine disturbances in systemic lupus erythematosus |
| Q27022855 | Cytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNA |
| Q34443260 | Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage |
| Q36740874 | Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9. |
| Q36684831 | Differences in codon bias and GC content contribute to the balanced expression of TLR7 and TLR9 |
| Q33637487 | Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus |
| Q36389926 | Endosomal Toll-like receptors in clinically overt and silent autoimmunity |
| Q51516999 | Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice. |
| Q42668884 | Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus |
| Q36637528 | Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus |
| Q28583551 | Estrogen receptor alpha modulates Toll-like receptor signaling in murine lupus |
| Q36754420 | Exacerbated autoimmunity in the absence of TLR9 in MRL.Fas(lpr) mice depends on Ifnar1 |
| Q85267997 | Expression and function of dectin-1 is defective in monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis |
| Q36527339 | Expression of TLR-7, MyD88, NF-kB, and INF-α in B Lymphocytes of Mayan Women with Systemic Lupus Erythematosus in Mexico |
| Q92382940 | Extrafollicular responses in humans and SLE |
| Q89060748 | Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation |
| Q38063202 | Fungal pathogens-a sweet and sour treat for toll-like receptors |
| Q51062941 | Gender bias in lupus: does immune response initiated in the gut mucosa have a role? |
| Q50332623 | Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells |
| Q89531004 | Gut microbiota differently contributes to intestinal immune phenotype and systemic autoimmune progression in female and male lupus-prone mice |
| Q30424263 | HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD |
| Q36098032 | Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells. |
| Q60046064 | Human Chorionic Gonadotropin Influences Systemic Autoimmune Responses |
| Q34208023 | Humanized TLR7/8 expression drives proliferative multisystemic histiocytosis in C57BL/6 mice |
| Q52364003 | Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus. |
| Q41168768 | Inhibiting TLR9 and other UNC93B1-dependent TLRs paradoxically increases accumulation of MYD88L265P plasmablasts in vivo |
| Q38557048 | Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics |
| Q37994060 | Integration of B cell responses through Toll-like receptors and antigen receptors |
| Q43538775 | Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. |
| Q33975488 | Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2. |
| Q26997316 | Intracellular nucleic acid sensors and autoimmunity |
| Q33715465 | Leaky Gut As a Danger Signal for Autoimmune Diseases |
| Q38177270 | Licensing Adaptive Immunity by NOD-Like Receptors |
| Q41813048 | Love triangle between Unc93B1, TLR7, and TLR9 prevents fatal attraction |
| Q91595484 | Low-dose 17α-ethinyl estradiol (EE) exposure exacerbates lupus renal disease and modulates immune responses to TLR7/9 agonists in genetically autoimmune-prone mice |
| Q36456019 | MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice |
| Q37734746 | Microbial TLR Agonists and Humoral Immunopathogenesis in HIV Disease |
| Q84199414 | Microparticles as autoadjuvants in the pathogenesis of SLE |
| Q37956536 | Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity |
| Q58788272 | Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren's Syndrome |
| Q37805517 | Modulation of toll-like receptor function has therapeutic potential in autoimmune disease |
| Q59136338 | Monogenic Lupus: A Developing Paradigm of Disease |
| Q35935783 | Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity |
| Q47739264 | Myd88 is required for disease development in a primary Sjögren's syndrome mouse model. |
| Q36991699 | NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. |
| Q50101560 | Negative regulation of B cell responses and self-tolerance to RNA-related lupus self-antigen |
| Q38099772 | Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity |
| Q55493201 | New application of anti-TLR monoclonal antibodies: detection, inhibition and protection. |
| Q28081728 | Nucleic Acid-Sensing Receptors: Rheostats of Autoimmunity and Autoinflammation |
| Q28534779 | Nucleic acid scavenging polymers inhibit extracellular DNA-mediated innate immune activation without inhibiting anti-viral responses |
| Q37819256 | Nucleic acid sensing Toll-like receptors in autoimmunity |
| Q39025992 | Nucleic acid-sensing TLRs: trafficking and regulation. |
| Q52691361 | Our Environment Shapes Us: The Importance of Environment and Sex Differences in Regulation of Autoantibody Production. |
| Q33620555 | Pathways leading to an immunological disease: systemic lupus erythematosus |
| Q91596386 | Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis |
| Q37991471 | Pattern recognition receptors in immune disorders affecting the skin. |
| Q51039778 | Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients. |
| Q90288795 | Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles |
| Q36583115 | Phenotypic and functional alterations of pDCs in lupus-prone mice. |
| Q55266542 | Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus. |
| Q40407608 | Plasmacytoid Dendritic Cells Respond Directly to Apoptotic Cells by Secreting Immune Regulatory IL-10 or IFN-α. |
| Q91868543 | Pneumococcal Polysaccharide Vaccine Ameliorates Murine Lupus |
| Q33790424 | RNA and imidazoquinolines are sensed by distinct TLR7/8 ectodomain sites resulting in functionally disparate signaling events |
| Q37397807 | RNA recognition by human TLR8 can lead to autoimmune inflammation |
| Q36300273 | RNA sensing by conventional dendritic cells is central to the development of lupus nephritis |
| Q93204275 | Recent clinical trends in Toll-like receptor targeting therapeutics |
| Q21131298 | Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination |
| Q37925064 | Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity |
| Q38078138 | Recognition of pathogen-associated nucleic acids by endosomal nucleic acid-sensing toll-like receptors |
| Q90221618 | Release from UNC93B1 reinforces the compartmentalized activation of select TLRs |
| Q38649480 | Relevant genetic polymorphisms and kidney expression of Toll-like receptor (TLR)-5 and TLR-9 in lupus nephritis. |
| Q33911256 | Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice |
| Q34655526 | Requirements for innate immune pathways in environmentally induced autoimmunity |
| Q36625438 | Rheumatoid factor B cell memory leads to rapid, switched antibody-forming cell responses |
| Q37059648 | Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells |
| Q38293111 | STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy? |
| Q37258447 | Scavenging nucleic acid debris to combat autoimmunity and infectious disease |
| Q92239589 | Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects |
| Q47912211 | Self-dsDNA in the pathogenesis of systemic lupus erythematosus. |
| Q61816755 | Sex and Pubertal Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone Concentration |
| Q28080459 | Sexual dimorphism in autoimmunity |
| Q36800112 | Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus |
| Q42210935 | Single nucleotide polymorphisms in genes encoding toll-like receptors 7, 8 and 9 in Danish patients with systemic lupus erythematosus |
| Q62067346 | Smaller CpG-Conjugated Gold Nanoconstructs Achieve Higher Targeting Specificity of Immune Activation |
| Q33909504 | Spontaneous activation of RNA-sensing pathways in autoimmune disease |
| Q40343247 | Spontaneous germinal centers and autoimmunity |
| Q90307219 | Stimulator of interferon genes agonists attenuate type I diabetes progression in NOD mice |
| Q93052232 | TLR7 Agonism Accelerates Disease and Causes a Fatal Myeloproliferative Disorder in NZM 2410 Lupus Mice |
| Q92239398 | TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner |
| Q37995556 | TLR7 and TLR9 in SLE: when sensing self goes wrong |
| Q35168231 | TLR7 and TLR9 trigger distinct neuroinflammatory responses in the CNS |
| Q35205325 | TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics |
| Q38656329 | TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells |
| Q37543854 | TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice |
| Q39647280 | TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus. |
| Q36585700 | TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation |
| Q92412704 | TLR9 signaling in fibroblastic reticular cells regulates peritoneal immunity |
| Q27023982 | TLRs and interferons: a central paradigm in autoimmunity |
| Q38929407 | Taking the STING out of TLR-driven autoimmune diseases: good, bad, or indifferent? |
| Q33420162 | Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases |
| Q47399059 | The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway |
| Q38117377 | The TLR family protein RP105/MD-1 complex: A new player in obesity and adipose tissue inflammation |
| Q26745929 | The germinal center antibody response in health and disease |
| Q28260075 | The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity |
| Q38095861 | The role of B lymphocyte stimulator in B cell biology: implications for the treatment of lupus |
| Q38158240 | The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity |
| Q36295343 | Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response |
| Q59127682 | Toll-Like Receptor 9 Deficiency Breaks Tolerance to RNA-Associated Antigens and Up-Regulates Toll-Like Receptor 7 Protein in Sle1 Mice |
| Q61805992 | Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease |
| Q93080297 | Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods |
| Q36302763 | Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice |
| Q37838577 | Toll-like receptor driven B cell activation in the induction of systemic autoimmunity |
| Q34015433 | Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis |
| Q97536785 | Toll-like receptor-9 (TLR-9) deficiency alleviates optic nerve injury (ONI) by inhibiting inflammatory response in vivo and in vitro |
| Q38832613 | Toll-like receptors and chronic inflammation in rheumatic diseases: new developments |
| Q52323268 | Toll-like receptors in lupus nephritis. |
| Q34650870 | Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment. |
| Q28067211 | Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments |
| Q35848152 | Toll-like receptors: potential targets for lupus treatment |
| Q38925152 | Toll-like receptors: promising therapeutic targets for inflammatory diseases |
| Q42268267 | Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis |
| Q38179688 | Trafficking of endosomal Toll-like receptors |
| Q38570333 | Translating nucleic acid-sensing pathways into therapies |
| Q57801953 | Triaryl Pyrazole Toll-Like Receptor Signaling Inhibitors: Structure-Activity Relationships Governing Pan- and Selective Signaling Inhibitors |
| Q35854962 | Unbiased modifier screen reveals that signal strength determines the regulatory role murine TLR9 plays in autoantibody production |
| Q35498054 | Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus |
| Q38150849 | Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models |
Search more.